ZIM
BBH icon

Zacks Investment Management’s VanEck Biotech ETF BBH Stock Holding History

Zacks Investment Management’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,114,205
Closed -$1.12M – 583
2017
Q2 		$1.12M Buy
+1,114,205
New +$134M 0.03% 341

Other funds holding BBH

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
BRM
Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Zacks Investment Management's BBH Position: Q3 2017 in Review

Zacks Investment Management sold out of VanEck Biotech ETF (BBH) in Q3 2017, closing a stake of 1,114,205 shares — an estimated $1.12M sold.

Zacks Investment Management first reported a position in BBH in Q2 2017 and held it in 1 quarter. The position peaked at $1.12M in Q2 2017. 79 funds tracked by Wall St. Rank hold BBH as of Q3 2017.

  • Zacks Investment Management reported no remaining VanEck Biotech ETF position as of Q3 2017 after selling out during the quarter.
  • Zacks Investment Management sold 1,114,205 VanEck Biotech ETF shares in Q3 2017, an estimated $1.12M.
  • Zacks Investment Management first reported a position in VanEck Biotech ETF in Q2 2017 and held it in 1 quarter.
  • Zacks Investment Management's VanEck Biotech ETF position peaked at $1.12M in Q2 2017.
  • 79 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2017.

Based on Zacks Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.